WA-AMAZON-WEB-SERVICES
14.10.2021 06:03:11 CEST | Business Wire | Press release
Today, Amazon Web Services (AWS), an Amazon.com, Inc. company (NASDAQ: AMZN), announced that NXP Semiconductors N.V. has selected AWS as its preferred cloud provider and is migrating the vast majority of its electronic design automation (EDA) workloads from NXP data centers to AWS. Running on the world’s leading cloud extends NXP’s efficiency and competitive edge in the design and verification of advanced semiconductors tailored to the requirements of automotive, industrial Internet of Things (IoT), mobile, and communications infrastructure businesses. The Netherlands-based company uses AWS’s proven global infrastructure and capabilities in high performance computing (HPC), storage, analytics, and machine learning to enhance collaboration and EDA throughput across dozens of its worldwide design centers, as well as to reduce costs with elastic scaling of compute resources and minimize scheduling risks for design projects. In addition, thanks to AWS’s virtually unlimited scale, NXP engineers gain more time to focus on innovation rather than managing compute resources.
Running on AWS, NXP aims to achieve long-term process improvements that transform how semiconductors are designed and tested. Before NXP can manufacture new chips, its designs undergo extensive testing and validation through the EDA process to ensure they are functionally safe, secure, high quality, and highly performant. NXP’s complex EDA workflows include front-end design, performance simulation, and verification, along with backend workloads that include timing and power analysis, design rule checks, and other applications to prepare a chip for production. Historically, semiconductor companies run these highly iterative workflows from on-premises data centers with fixed compute capacity. However, because of the massive compute power involved for each cycle and the increasing complexity of chip designs, producing a new device can take many months or even years unless the companies accurately forecast and install additional compute infrastructure. In contrast, by powering its EDA with AWS, NXP gains the scale and agility to advance multiple projects at the same time on demand, regardless of their complexity, and run dozens of performance simulations in parallel to accelerate time to result.
To better manage the scale and complexity of its design activities, NXP relies on AWS analytics and machine learning services to continuously refine its research and development workflows. NXP uses Amazon QuickSight (AWS’s machine learning-powered business intelligence service built for the cloud) to generate more powerful engineering and operational insights that help increase workflow efficiency. For example, by rapidly translating results from one step of testing into modifications for another, NXP can reduce the time required to iterate chip designs. NXP also uses Amazon SageMaker (AWS’s service that helps developers and data scientists build, train, and deploy machine learning models quickly in the cloud and at the edge) to optimize how it structures compute, storage, and third-party software application licenses. To support this work, NXP is building a data lake on AWS using Amazon Simple Storage Service (Amazon S3) and AWS Glue (AWS’s service for simply and cost-effectively extracting, transforming, and loading data).
In addition, NXP takes advantage of AWS’s range of specialized instances for HPC to further streamline its EDA workflows. The selection of instance types allows NXP to meet the unique requirements of each design project while also achieving a high degree of price performance. NXP uses Amazon FSx for Lustre (AWS’s service that provides cost-effective, high-performance, scalable storage for compute workloads like EDA) to store petabytes of design simulation data and make it quickly available for analysis.
“We believe cloud-based EDA is critical to accelerating semiconductor innovation and getting new designs to market faster to power an increasingly digital world where more and more devices and infrastructure are connected. AWS gives us the best scale, global presence, and selection of compute and storage options, with continuous improvements in price performance, that we need,” said Olli Hyyppa, CIO and senior vice president, NXP Semiconductors N.V. “We’re excited to expand our relationship with AWS to power the next generation of EDA workloads in the cloud. This will give precious time back to our design engineers to focus on innovation and lead the transformation of the semiconductor industry.”
“At AWS, we consider ourselves to be a community of builders, and this engagement with NXP reinforces what’s possible when you free builders to work in the best environments, with the infrastructure and capabilities they need,” said Dave Brown, vice president of Amazon Elastic Compute Cloud, Amazon Web Services, Inc. “By shifting their EDA workloads to AWS, NXP designers will have access to the best tools available for collaborating on semiconductor design and development around the world. This move will help NXP produce chips that power innovation in IoT, connected cars, and more. We’re proud to support a leading driver of innovation in the semiconductor industry, and we look forward to seeing what becomes possible when chip design moves to the cloud at such a large scale.”
About Amazon Web Services
For over 15 years, Amazon Web Services has been the world’s most comprehensive and broadly adopted cloud offering. AWS has been continually expanding its services to support virtually any cloud workload, and it now has more than 200 fully featured services for compute, storage, databases, networking, analytics, machine learning and artificial intelligence (AI), Internet of Things (IoT), mobile, security, hybrid, virtual and augmented reality (VR and AR), media, and application development, deployment, and management from 81 Availability Zones within 25 geographic regions, with announced plans for 24 more Availability Zones and eight more AWS Regions in Australia, India, Indonesia, Israel, New Zealand, Spain, Switzerland, and the United Arab Emirates. Millions of customers—including the fastest-growing startups, largest enterprises, and leading government agencies—trust AWS to power their infrastructure, become more agile, and lower costs. To learn more about AWS, visit aws.amazon.com
.
About Amazon
Amazon is guided by four principles: customer obsession rather than competitor focus, passion for invention, commitment to operational excellence, and long-term thinking. Amazon strives to be Earth’s Most Customer-Centric Company, Earth’s Best Employer, and Earth’s Safest Place to Work. Customer reviews, 1-Click shopping, personalized recommendations, Prime, Fulfillment by Amazon, AWS, Kindle Direct Publishing, Kindle, Career Choice, Fire tablets, Fire TV, Amazon Echo, Alexa, Just Walk Out technology, Amazon Studios, and The Climate Pledge are some of the things pioneered by Amazon. For more information, visit amazon.com/about
and follow @AmazonNews.
About NXP Semiconductors
NXP Semiconductors N.V. (NASDAQ: NXPI) enables secure connections for a smarter world, advancing solutions that make lives easier, better, and safer. As the world leader in secure connectivity solutions for embedded applications, NXP is driving innovation in the automotive, industrial & IoT, mobile, and communication infrastructure markets. Built on more than 60 years of combined experience and expertise, the company has approximately 29,000 employees in more than 30 countries and posted revenue of $8.61 billion in 2020. Find out more at www.nxp.com
.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211013006195/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Sun Pharma signs Definitive Agreement to Acquire Organon27.4.2026 01:51:00 CEST | Press release
Organon stockholders to receive US$ 14.00 per share in cashThe deal values Organon at EV of US$ 11.75 billionCombined Business leverages complementary portfolios and global scale for sustained long‑term value creation Sun Pharmaceutical Industries Limited(Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries and/or associated companies, “Sun Pharma”) and Organon & Co. (NYSE: OGN) (“Organon”) today announced that they have entered into a definitive agreement under which Sun Pharma will acquire all outstanding shares of Organon for US$ 14.00 per share in an all‑cash transaction with an enterprise valuation of US$ 11.75 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260426881370/en/ Organon is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, in 2021. Organon has a legacy of deep trust and strong brand equit
Andersen Global udvider sin tilstedeværelse i Afrika med lanceringen af medlemsfirma i Cameroun26.4.2026 20:56:00 CEST | Pressemeddelelse
Andersen Global træder ind på det camerounske marked, idet Phoenix Advisory bliver medlemsfirma og overgår til Andersen-brandet. Andersen in Cameroun er et specialiseret rådgivningsfirma, der leverer strategiske, erhvervsmæssige, finansielle og operationelle rådgivningsydelser til organisationer i forskellige vækstfaser. Firmaet er grundlagt af fagfolk med erfaring fra store internationale organisationer og kombinerer et stærkt lokalt og centralafrikansk funderet kendskab til forretningsmæssige, juridiske og skattemæssige regler med en skræddersyet tilgang, der har til formål at skabe konkrete og målbare resultater for klienterne. "Overgangen til Andersen-brandet afspejler vores engagement i at vokse sammen med vores kunder og imødekomme stadig mere komplekse behov," udtalte administrerende partner Albert Désiré Zang. "Vi tror på, at langsigtet succes skabes gennem tillid, kvalitet og vedvarende support. At blive et medlemsfirma styrker vores evne til at levere gennemtænkte, bæredygtig
PMCOrganometallix Announces Price Increase on All Products24.4.2026 22:55:00 CEST | Press release
Due to significant changes in market conditions, PMC Organometallix, Inc. announces that effective May 1, 2026, or as contracts permit, prices across all product lines globally will increase by 10-25%. This adjustment is driven by sustained cost pressures from key inputs including rising raw material costs and escalating freight and logistics expenses. While the company has been absorbing these increases, the current economic environment brought on by the geopolitical crisis of the Iran conflict requires this adjustment to continue providing the high-quality, consistent materials and supply reliability that customers expect. PMC Organometallix will implement these changes in a transparent, collaborative manner and values your partnership while navigating these economic challenges. Customers with questions or to discuss a specific situation should contact their account representative. About PMC Group PMC Group is a growth-oriented, diversified, global chemicals and plastics company deli
Frankfurt Higher Regional Court upholds BESREMi® arbitral award in favor of AOP Health24.4.2026 18:52:00 CEST | Press release
Today, the Higher Regional Court of Frankfurt upheld the February 20251 partial final ICC arbitral award in favor of AOP Orphan Pharmaceuticals GmbH (“AOP Health”) in its dispute with PharmaEssentia Corp. (“PharmaEssentia”). The ruling confirms the award which found the Taiwanese company to be liable for certain damages. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260424005227/en/ Portrait Dr. Rudolf Widmann, Founder AOP Health Credit: AOP Health/Daniel Ospelt Dr. Rudolf Widmann, one of the two founders of AOP Health, explains: “We very much welcome the Frankfurt Higher Regional Court’s decision that confirms our position. In the interest of our patients, we are dedicated to maintaining stable and sustainable access to BESREMi® and to responsibly navigating future challenges.” The Product in Dispute The conflict centers around BESREMi® (ropeginterferon alfa-2b), a product launched in 2019 and developed by AOP Health into
Compass Pathways Announces FDA Granted NDA Rolling Review Request and Awarded Commissioner's National Priority Voucher24.4.2026 16:37:00 CEST | Press release
Compass is the most advanced company in classic psychedelics and has generated positive data from two ongoing large, well controlled Phase 3 clinical trials, designed to uphold the highest regulatory standardsFDA grants Compass NDA rolling submission and review request, based on Phase 3 dataCNPV awarded for COMP360, Compass’ proprietary formulation of synthetic psilocybin, for treatment-resistant depression (TRD)CNPV further accelerates momentum and Compass is confident and ready to deliver for patients Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the U.S. Food and Drug Administration (FDA) granted Compass NDA rolling review request and selected COMP360, Compass’ proprietary formulation of synthetic psilocybin, for the Commissioner's National Priority Voucher (CNPV) program for treatment-resistant depression (TRD). Companies selected for the voucher program will be en
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
